Nev. Admin. Code § 453.530 - Schedule III
1. Schedule III consists of the drugs and
other substances listed in this section, by whatever official, common, usual,
chemical or trade name designated.
2. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances having a stimulant
effect on the central nervous system, including their salts, isomers and salts
of such isomers, whenever the existence of such salts, isomers and salts of
isomers is possible within the specific chemical designation, is hereby
enumerated on schedule III, including:
(a)
Those compounds, mixtures or preparations in dosage unit form containing any
substance listed in schedule II which has a stimulant effect on the central
nervous system, which compounds, mixtures or preparations were listed on August
25, 1971, as excepted compounds under the regulations of the Drug Enforcement
Administration of the United States Department of Justice, and any other drug
of the same quantitative composition as a drug shown on the list or which is
the same except that it contains a lesser quantity of controlled
substances;
(b)
Benzphetamine;
(c)
Chlorphentermine;
(d) Clortermine;
or
(e) Phendimetrazine.
For the purposes of this subsection, "isomer" includes the optical, position or geometric isomer.
3. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances having a depressant
effect on the central nervous system is hereby enumerated on schedule III:
(a) Any substance which contains any quantity
of a derivative of barbituric acid or any salt thereof;
(b) Chlorhexadol;
(c) Embutramide;
(d) Lysergic acid;
(e) Lysergic acid amide;
(f) Methyprylon;
(g) Sulfondiethylmethane;
(h) Sulfonethylmethane;
(i) Sulfonmethane;
(j) Any compound, mixture or preparation
containing amobarbital, secobarbital, pentobarbital or any salt thereof and one
or more other active medicinal ingredients, which are not listed in any
schedule;
(k) Any suppository
dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of
any of these drugs approved by the Food and Drug Administration of the United
States Department of Health and Human Services for marketing only as a
suppository; or
(l) Tiletamine and
zolazepam or any salt thereof. (Some trade or other names for a
tiletamine-zolazepam combination product: Telazol. Some trade or other names
for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other
names for zolazepam:
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one,
flupyrazapon).
4.
Nalorphine is hereby enumerated on schedule III.
5. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture or preparation
containing any of the following narcotic drugs or their salts, calculated as
the free anhydrous base or alkaloid, in quantities is hereby enumerated on
schedule III:
(a) Not more than 1.8 grams of
codeine per 100 milliliters or not more than 90 milligrams per dosage unit,
with an equal or greater quantity of an isoquinoline alkaloid of
opium;
(b) Not more than 1.8 grams
of codeine per 100 milliliters or not more than 90 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized therapeutic
amounts;
(c) Not more than 1.8
grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per
dosage unit, with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts;
(d) Not more
than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15
milligrams per dosage unit, with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts;
(e)
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or
not more than 25 milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts; or
(f) Not more than 50 milligrams of morphine
per 100 milliliters or per 100 grams, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts.
6. Unless listed in another schedule, any
material, compound, mixture or preparation which contains any quantity of:
(a) N-methylephedrine, its optical isomers,
salts and salts of optical isomers;
(b) Hydriodic acid; or
(c) Hydrogen iodide gas,
are, as immediate precursors, controlled, the control of which is necessary to prevent, curtail or limit the manufacture of the controlled substances methamphetamine and N, N-dimethylamphetamine.
7. Except as otherwise provided in
subsections 8 and 9, or specifically excepted or listed in another schedule,
any material, compound, mixture or preparation containing any quantity of
anabolic steroids, including their salts, isomers, esters and salts of isomers,
whenever the existence of such salts of isomers is possible within the specific
chemical designation, is hereby enumerated on schedule III:
(a) Androisoxazole;
(b) Androstenediol;
(c) Bolandiol;
(d) Bolasterone;
(e) Boldenone;
(f) Chlormethandienone;
(g) Clostebol;
(h) Chorionic gonadotropin (HCG);
(i) Dehydrochlormethyltestosterone;
(j) Dihydromesterone;
(k) Drostanolone;
(l) Ethylestrenol;
(m) Fluoxymesterone;
(n) Formebolone;
(o) Formyldienolone;
(p) 4-Hydroxy-19-nortestosterone;
(q) Mesterolone;
(r) Methandrenone;
(s) Methandriol;
(t) Methandrostenolone;
(u) Methenolone;
(v) 17-Methyltestosterone;
(w) Methyltrienolone;
(x) Mibolerone;
(y) Nandrolone;
(z) Norbolethone;
(aa) Norethandrolone;
(bb) Normethandrolone;
(cc) Oxandrolone;
(dd) Oxymesterone;
(ee) Oxymetholone;
(ff) Quinbolone;
(gg) Stanolone;
(hh) Stanozolol;
(ii) Stenbolone;
(jj) Testolactone;
(kk) Testosterone; or
(ll) Trenbolone.
8. Any anabolic steroid or chorionic
gonadotropin (HCG) described in subsection 7 which is used solely for
implantation or injection in cattle or any other nonhuman species and is
approved by the Food and Drug Administration for that use is not a controlled
substance.
9. The following
classifications are not controlled substances for the purposes of this section:
(a) Oral combinations containing therapeutic
doses of estrogen and androgen;
(b)
Parenteral preparations containing therapeutic doses of estrogen and
androgen;
(c) Topical preparations
containing androgens or combinations of androgen and estrogen; and
(d) Vaginal preparations.
10. Ketamine, including its salts,
isomers and salts of isomers, is hereby enumerated on schedule III.
11. Synthetic Dronabinol in sesame oil
encapsulated in a soft gelatin capsule in a drug product approved by the Food
and Drug Administration (some trade or other names:
(6aR-trans)-6a,7,8,10a-tetrahydro-6; 6,9-trimethyl-3-pentyl-6H-dibenzo
[b,d]pyran- 1-ol; (-)-delta-9-(trans)-tetrahydrocannabinol; Marinol) is hereby
enumerated on schedule III.
12.
Gamma-hydroxybutyrate prepared by a registered pharmaceutical manufacturer of
the Food and Drug Administration which is properly labeled, including lot
numbers, and is available for medicinal purposes through a distribution system
approved by the Food and Drug Administration is hereby enumerated on schedule
III.
13. Human growth hormone (HGH)
is hereby enumerated on schedule III.
14. Any material, compound, mixture or
preparation containing buprenorphine, including its salts, is hereby enumerated
on schedule III.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.